PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: General Electric Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge - Expansion of relationship with SBC furthers GE's commitment to open innovation in healthcare - StevenageCatalyst.com / GEHealthcare.com
GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge

 

NewswireToday - /newswire/ - Chalfont St Giles, United Kingdom, 2014/12/15 - Expansion of relationship with SBC furthers GE's commitment to open innovation in healthcare - StevenageCatalyst.com / GEHealthcare.com. NYSE: GE

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GE Healthcare Life Sciences is expanding its relationship with Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, by supporting SBC’s open innovation challenge in neurodegenerative disease. The link-up, which reflects GE Healthcare’s drive to advance research in the diagnosis of neurological disorders, builds on its presence at SBC, where the company opened a Technology Laboratory in October 2013. Hundreds of millions of people worldwide are affected by neurodegenerative disorders such as epilepsy, Parkinson’s and Alzheimer’s disease, and SBC’s open innovation challenge was established to help address this growing global problem.

The open innovation challenge, which will stimulate interaction between academics, industry and charities, was launched in May 2014 by SBC, Manchester Integrating Medicine and Innovative Technology (MIMIT)1 and six leading Academic Health Science Centre Technology Transfer Organizations2. Proposals from academic teams for research in two fields - biomarkers for diagnosis and patient stratification, and inflammation/neurodegeneration - will be reviewed by a panel of industry, public sector and research charity experts including sponsors such as GE Healthcare Life Sciences. Selected projects will be announced at the beginning of 2015.

Joining the challenge supports GE Healthcare’s MIND (Make an Impact on Neurological Disorders) initiative, which is dedicated to improving the prediction, detection and diagnosis of neurological disorders.

Ger Brophy, Chief Technology Officer of GE Healthcare Life Sciences, said,“We are excited to be joining the SBC Open Innovation Challenge. We strongly believe that collaboration between industry and academia is the way to drive innovation, and this SBC initiative supports our goal of finding new, better ways for physicians to detect and diagnose these most difficult of diseases.”

Martino Picardo, CEO of Stevenage Bioscience Catalyst, said,“We are delighted to welcome GE Healthcare Life Sciences to our neurodegenerative diseases challenge. Broadening the scope of organisations associated with this initiative increases the range of expertise available to the academic researchers and everyone else involved - a real case of open innovation in action. The link-up also strengthens our productive relationship with GE.”

Make an Impact on Neurological Disorders (MIND)
Between 2010 and 2020, GE Healthcare plans to invest over $500 million in research into neurological disorders. The investment crosses all lines of GE Healthcare's global business and focuses on developing new neurology diagnostic solutions, educating consumers, and expanding research already in progress. Target areas include diagnosing post-traumatic stress disorder, Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, concussion and traumatic brain injury. For decades, GE Healthcare has produced diagnostics scanners, imaging agents and software to help physicians see more clearly inside the brain and aid better patient management. In 2013, a $60 million investment with National Football League to develop new MR technology for traumatic brain injury was announced, including a $20 million Global Challenge to advance diagnosis and prognosis of mild TBI.

About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.

About Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst (stevenagecatalyst.com)is the UK’s first open innovation bioscience campus, pioneering a unique culture to drive early stage bioscience technology and company development, and building a thriving community. It is backed by £38m of funding from its founding partners GlaxoSmithKline, the Wellcome Trust, the Department for Business, Innovation and Skills, the Technology Strategy Board and the former East of England Development Agency. Consisting of an Incubator, an Accelerator and a Hub, covering 60,000 sq ft of laboratory, office and networking space, the independent facility houses a range of companies, from virtual and start-up firms to those which are more established, as well as other organisations. Co-located with GlaxoSmithKline on the Stevenage campus, Stevenage Bioscience Catalyst is in the unique position of operating in proximity to the expertise and resources of a major pharmaceutical company, close to both London and Cambridge.

1 Stevenage Bioscience Catalyst and MIMIT launch Open Innovation Challenge in Neurodegenerative Disease
2 AHSC Technology Transfer Organisations involved: Cambridge Enterprise, Imperial Innovations, King’s Business, UCL Business, University of Manchester Intellectual Property, and Isis Innovations (Oxford University)

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: General Electric Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Neurodegenerative Disease | GE Healthcare
Publisher Contact: Ursula Oliver - GE Healthcare 
+44(0)14 9454 5426 ursula.oliver[.]ge.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any General Electric Company securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From General Electric Company / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)